Literature DB >> 26556467

Influence of aripiprazole once monthly on clinical symptoms and cognitive function in two schizophrenia patients: Preliminary results.

Hidenobu Suzuki1, Gou Sekiguchi2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26556467     DOI： 10.1111/pcn.12374

Source DB:  PubMed          Journal:  Psychiatry Clin Neurosci        ISSN： 1323-1316            Impact factor:   5.188


× No keyword cloud information.
  3 in total

1.  Place of the partial dopamine receptor agonist aripiprazole in the management of schizophrenia in adults: a Delphi consensus study.

Authors:  Pierre-Michel Llorca; Philippe Nuss; Éric Fakra; Isabelle Alamome; Dominique Drapier; Wissam El Hage; Renaud Jardri; Stéphane Mouchabac; Marc Rabbani; Nicolas Simon; Marie-Noëlle Vacheron; Jean-Michel Azorin
Journal:  BMC Psychiatry       Date:  2022-05-28       Impact factor: 4.144

2.  The effect of switching from oral low-dose aripiprazole to aripiprazole once-monthly 300 mg on the quality of life in three patients with schizophrenia.

Authors:  Hidenobu Suzuki; Hiroyuki Hibino; Yuichi Inoue; Hideo Matsumoto; Katsunaka Mikami
Journal:  SAGE Open Med Case Rep       Date:  2017-05-26

3.  Effects of Amisulpride Adjunctive Therapy on Working Memory and Brain Metabolism in the Frontal Cortex of Patients with Schizophrenia: A Preliminary Positron Emission Tomography/Computerized Tomography Investigation.

Authors:  Jeong Ha Park; Ji Son Hong; Sun Mi Kim; Kyung Joon Min; Un Sun Chung; Doug Hyun Han
Journal:  Clin Psychopharmacol Neurosci       Date:  2019-05-31       Impact factor: 2.582
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.